Tag - THRM

Thermage, Inc. (Nasdaq: THRM) Thursday reiterated revenue guidance of between $65 million and $68 million, which would be a 20% to 25% growth rate, for the fiscal year 2007 ending Dec. 31.

“We’re very comfortable with those numbers,” CFO Laureen DeBuono told investors at the Bank of America 2007 Health Care Conference in Las Vegas

On May 1, the Hayward, Calif.-based company reported revenues of $15.2 million for the first quarter ended March 31, up from $12.4 million a year earlier. The company reported first-quarter net income of $0.1 million, or breakeven earnings per share, up from a loss of $2.8 million, or $0.68 a share, in the first three months of 2006.

“Thermage is the leader in the fastest growing global aesthetic market segment,” DeBuono said during the presentation. “We are the industry’s first and only disposable business model.”

The company, founded in 1995, manufactures and markets devices that tighten, contour and rejuvenate skin. In her presentation, DeBuono emphasized the company’s intellectual property - it holds 99 patents, 29 of which are in the United States – and FDA approval.

About 30% of the company’s devices are installed “non-core” offices, or physicians who are not dermatologists or plastic surgeons, she said. “There’s a huge growth opportunity” in the non-core market, she said.